The stock of Cellectis SA (ADR) (NASDAQ:CLLS) is a huge mover today! The stock increased 3.68% or $0.64 on November 25, hitting $18.05. About 92,198 shares traded hands. Cellectis SA (ADR) (NASDAQ:CLLS) has declined 39.70% since April 22, 2016 and is downtrending. It has underperformed by 45.10% the S&P500.
The move comes after 5 months positive chart setup for the $622.33M company. It was reported on Nov, 25 by Barchart.com. We have $19.31 PT which if reached, will make NASDAQ:CLLS worth $43.56M more.
According to Zacks Investment Research, “Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France.”
More news for Cellectis SA (ADR) (NASDAQ:CLLS) were recently published by: Marketwatch.com, which released: “/quotes/zigman/3870025/realtime” on March 25, 2015. Quotes.Wsj.com‘s article titled: “DOW JONES, A NEWS CORP COMPANY” and published on March 21, 2015 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.